Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies

Journal Article · · Current Opinion in HIV and AIDS
 [1];  [2];  [3]
  1. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  2. Univ. of Pennsylvania, Philadelphia, PA (United States)
  3. Los Alamos National Lab. (LANL), Los Alamos, NM (United States); New Mexico Consortium, Los Alamos, NM (United States)
The surface of the HIV-1 Env glycoprotein, the target of neutralizing antibodies, is extensively covered by N-linked glycans that create a glycan shield. Broadly neutralizing antibodies (bNAbs), the primary targets of HIV-1 vaccine design, have to negotiate this glycan shield. Here, we review the barriers and opportunities that the HIV-1 glycan shield presents for vaccine induction of bNAbs.
Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE Laboratory Directed Research and Development (LDRD) Program
Grant/Contract Number:
89233218CNA000001
OSTI ID:
1756809
Report Number(s):
LA-UR--20-26631
Journal Information:
Current Opinion in HIV and AIDS, Journal Name: Current Opinion in HIV and AIDS Journal Issue: 5 Vol. 15; ISSN 1746-630X
Publisher:
Wolters Kluwer Health, Inc.Copyright Statement
Country of Publication:
United States
Language:
English

References (53)

Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies journal July 2014
Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies journal September 2014
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G journal May 2016
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization journal July 2019
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein journal March 2016
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies journal August 2016
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation journal April 2017
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model journal October 2017
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen journal August 2018
Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth journal October 2018
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition journal April 2020
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design journal January 2019
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design journal November 2015
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies journal September 2016
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope journal March 2018
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies journal August 2018
Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization journal August 2018
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability journal November 2019
Protein and Glycan Mimicry in HIV Vaccine Design journal May 2019
Microsecond Dynamics and Network Analysis of the HIV-1 SOSIP Env Trimer Reveal Collective Behavior and Conserved Microdomains of the Glycan Shield journal October 2017
Exploiting the defensive sugars of HIV-1 for drug and vaccine design journal April 2007
Global site-specific N-glycosylation analysis of HIV envelope glycoprotein journal March 2017
Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies journal June 2015
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals journal January 2017
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design journal December 2015
Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site journal September 2016
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding journal November 2017
Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer journal September 2018
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle journal September 2019
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques journal May 2019
Recent progress in broadly neutralizing antibodies to HIV journal October 2018
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo journal August 2017
How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design journal January 2017
Germline-targeting immunogens journal January 2017
Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development journal January 2017
Polyvalent vaccine approaches to combat HIV-1 diversity journal January 2017
Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies journal December 2014
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen journal June 2015
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer journal March 2016
Targeted selection of HIV-specific antibody mutations by engineering B cell maturation journal December 2019
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies journal March 2017
Multiple roles for HIV broadly neutralizing antibodies journal October 2019
Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits journal January 2020
Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers journal February 2017
The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120 journal July 2002
Structure and Immune Recognition of the HIV Glycan Shield journal May 2018
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention journal April 2020
Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein journal October 2016
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site journal May 2015
Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C journal September 2016
Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation journal May 2018
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies journal September 2019
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core journal November 2018

Similar Records

Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies
Journal Article · Tue Mar 14 20:00:00 EDT 2017 · Science Translational Medicine · OSTI ID:1406204

Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
Journal Article · Mon Nov 11 19:00:00 EST 2019 · Immunity · OSTI ID:1577147

Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
Journal Article · Tue Mar 27 20:00:00 EDT 2018 · Nature Communications · OSTI ID:1624084